ACCORSI BUTTINI, EUGENIA
 Distribuzione geografica
Continente #
NA - Nord America 205
EU - Europa 169
AS - Asia 60
SA - Sud America 2
OC - Oceania 1
Totale 437
Nazione #
US - Stati Uniti d'America 203
IT - Italia 73
FI - Finlandia 30
DE - Germania 19
HK - Hong Kong 18
CN - Cina 17
SG - Singapore 17
CZ - Repubblica Ceca 8
GB - Regno Unito 8
IE - Irlanda 8
SE - Svezia 6
IN - India 5
PL - Polonia 5
UA - Ucraina 5
FR - Francia 4
BR - Brasile 2
CA - Canada 2
GR - Grecia 2
AU - Australia 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 437
Città #
Chandler 32
Helsinki 27
Brescia 19
New York 19
Hong Kong 18
Boardman 16
Fairfield 15
Ashburn 14
Seattle 14
Shanghai 12
Singapore 10
Barlassina 8
Brno 8
Dublin 8
Woodbridge 8
Milan 7
Wilmington 7
Cambridge 6
Jacksonville 6
Houston 5
Pune 5
Wroclaw 5
Pescara 4
Princeton 4
Rome 4
Lappeenranta 3
Athens 2
Bosio 2
Casanova Lonati 2
Chicago 2
Chiswick 2
Des Moines 2
Mazzano 2
Montesilvano Marina 2
São Paulo 2
Turin 2
Beijing 1
Bergamo 1
Brooklyn 1
Cachan 1
Florence 1
Hounslow 1
Jinan 1
Kocaeli 1
La Spezia 1
Lequio Tanaro 1
London 1
Los Angeles 1
Malmo 1
Margherita di Savoia 1
Melbourne 1
Munich 1
Ningbo 1
North York 1
Ramallah 1
Redwood City 1
Riyadh 1
Roverbella 1
Strasbourg 1
Tianjin 1
Totale 328
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 115
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 44
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 42
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 40
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 31
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 28
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 25
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 21
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 19
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 19
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 18
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 17
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 12
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 11
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 7
Totale 449
Categoria #
all - tutte 4.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 1 10 9 6 6 7 4 1 5
2020/202132 1 2 2 1 1 7 0 4 2 7 1 4
2021/202223 0 0 0 6 0 1 0 1 0 4 7 4
2022/2023132 7 2 3 18 12 23 0 13 17 7 16 14
2023/2024207 6 7 18 14 24 40 4 14 22 4 4 50
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 449